Shandong Sine Pharmaceutical Co., Ltd. is a comprehensive pharmaceutical enterprise integrating manufacturing, sales and R&D by Shanghai Shangyi Sine Co., Ltd., Shandong Plain Pharmaceutical Factory and Dezhou Borun Pharmaceutical Technology Co., Ltd., which is a national food and drug supervision. Authority of the Authority for the manufacture of psychotropic drugs. The factory covers an area of 40 mu, with a construction area of 12,000 m2. It has a solid preparation workshop, five raw material medicine workshops and supporting laboratory, environmental protection, warehousing and other facilities. There are 83 approved products (62 preparations, 21 raw materials). The annual production capacity: 3 billion tablets (granules) and 150 tons of raw materials, with self-support import and export rights, the products are sold to more than 20 provinces, municipalities and autonomous regions nationwide, and are favored by customers.

Since its establishment in April 2013, Shandong Xinyi Pharmaceutical has been under the leadership of Shanghai Pharmaceuticals and the board of directors of the company. It has strengthened its foundation, strictly controlled risks, and has made operational efforts to successfully complete the first “three-year plan” strategic goal. The second “three-year plan” and “three-year re-engineering” strategic objectives were completed one year ahead of schedule. Important indicators such as asset preservation and value-added and return on investment were higher than the expectations of the project.